-
CHMP Favors Zeposia as Oral Treatment for Active RRMS in EU
A branch of the European Medicines Agency is recommending European Union approval of Zeposia (ozanimod) oral capsules to treat adults with active RRMS. Click here to read more.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.